Havtop 25 Tablet contains Topiramate 25 mg, an antiepileptic medication primarily used to manage and prevent seizures in patients with epilepsy. Topiramate acts by stabilizing neuronal membranes and inhibiting excitatory neurotransmission, thereby reducing seizure frequency and severity. It is also indicated for the prophylaxis of migraine headaches in adults. Havtop 25 is prescribed as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. The dosage should be individualized based on patient response and tolerability, typically initiated at a low dose with gradual titration to minimize adverse effects. Common side effects include dizziness, fatigue, cognitive disturbances, weight loss, and paresthesia. Patients should be monitored for metabolic acidosis, kidney stones, and ocular problems such as glaucoma. Caution is advised in patients with renal impairment, a history of kidney stones, or metabolic acidosis. Concomitant use with other antiepileptic drugs may require dose adjustments. Havtop 25 should be used under strict medical supervision, with regular follow-up to assess efficacy and safety. It is contraindicated in patients with hypersensitivity to Topiramate or any component of the formulation. Pregnant or breastfeeding women should consult their physician before use.